Solentim & Valitacell announce collaboration
Integrating Valitacell’s in-line analytical profiling technologies with Solentim’s innovative image-driven liquid handling and cell measurement technology will transform workflows, creating a streamlined platform which synergises attribute-rich profiling of clones and earlier decision making.
"We strive to support our customers in developing more and better biopharmaceuticals to treat patients. By continually innovating to create unique and unrivalled technologies, we bring practical solutions to the problems of the drug discovery and development process"
We provide solutions for customers working across cell line development:
VIEW OUR WEBINAR
"How a Top-5 Pharma Doubled the Speed of Cell Line Development"
Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies
21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification
Solentim to Present and Exhibit at the ELRIG “CRISPR in Drug Discovery 2019” Conference in Oxford, UK
NEWS – Bournemouth, 11th February 2019: Solentim, a global leader in cell line development instrumentation, is pleased to announce they will be attending the ELRIG CRISPR in Drug Discovery 2019: From
In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell
Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development
NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This
NEWS – Bournemouth, UK – 10th January 2019: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce the appointment of Claire Richards as their new
NEWS - Bournemouth, UK – 3rd January 2019: Solentim, the innovator and leader in Cell Line Development instrumentation, is pleased to announce they will be exhibiting at the Annual PepTalk
In this latest blog by Solentim’s Dr Ian Taylor, the advent of digital biology is discussed. This is compared and contrasted with smarter automation, transformative new biology and better control
Never far from scientific and mainstream news, CRISPR is regularly hailed as one of the most important scientific discoveries of our time. With potential applications across wide-ranging fields from medicine
Aaron Figg & Ian Taylor at the Deloitte UK Technology Fast 50 Solentim named as one of the top 50 fastest growing UK technologies companies of
Aaron Figg, Dave Elverd, Mr (Ian) Angus Campbell (Her Majesty’s Lord-Lieutenant of Dorset), Ian Taylor, Sky Jiang Solentim’s business excellence and expertise in cell line development